机器人辅助手术在整合医疗网络中的总诊疗成本分析
该研究纳入2020年6月至2023年7月期间接受开放、腹腔镜或机器人辅助手术的成人患者共14,315例,比较围术期关键指标与边际贡献。结果显示机器人手术较腹腔镜和开放手术可缩短住院时间、降低中转开腹率和手术部位感染率,且部分术式边际贡献不劣于或高于其他方式。
要点
- 机器人手术较腹腔镜缩短住院时间、降低中转开腹率及手术部位感染率
- 机器人手术较开放手术缩短住院时间并降低再入院、ICU入住及感染率
- 住院结肠切除中腹腔镜边际贡献/住院日显著高于开放手术
核心结论
- 机器人辅助手术可改善临床结局,且边际贡献相似或更高,可能降低总诊疗成本。
研究设计与样本
- 回顾性队列研究,纳入2020年6月至2023年7月期间接受开放、腹腔镜或机器人辅助手术的18岁以上患者,共14,315例可分析手术。
主要发现
- 与腹腔镜相比,机器人手术的住院时间更短(1天 vs 2天),中转开腹率更低(1.9% vs 5.1%),手术部位感染率更低(0.1% vs 1.5%),差异均有统计学意义(p<0.05)。
- 与开放手术相比,机器人手术的住院时间更短(2天 vs 5天),30天再入院率更低(3.8% vs 7.2%),ICU入住率更低(0.9% vs 22.1%),手术部位感染率更低(0.2% vs 1.9%),差异均有统计学意义(p<0.05)。
- 住院结肠切除中,三组间边际贡献无显著差异(p>0.05),但腹腔镜的边际贡献/住院日显著高于开放手术(2929.15 $ vs 1708.97 $,p<0.05)。
- 门诊胆囊切除、腹股沟疝和腹壁疝中,机器人组边际贡献高于开放和腹腔镜组,但差异无统计学意义。
- Roux-en-Y胃旁路术和袖状胃切除术中,机器人手术的边际贡献和边际贡献/住院日均显著更高。
临床怎么用
- 在评估机器人手术时,除临床结局外应纳入边际贡献和边际贡献/住院日等成本指标进行综合决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Adoption of robotic-assisted surgery (RAS) is limited due to several factors including access and cost. Our aim is to evaluate the total cost of care by analyzing key performance indicators and contribution margins of RAS in our healthcare system. METHODS: We included patients > 18 yo who underwent open, laparoscopic (Lap), and robotic-assisted procedures (Robotic) between June 2020 and July 2023. Key performance Indicators included operating room (OR) time, hospital length of stay (LOS), ICU admission, conversion to open, 30-day readmission, and surgical site infection (SSI). Contribution margins (CM) and CM/LOS were calculated. Statistical analyses included analysis of variance (ANOVA), the Kruskal-Wallis test, and the Chi-square test. RESULTS: The total number of addressable procedures was 14,315. Compared to Lap, robotic procedures were associated with significantly shorter LOS, conversion to open rate, and SSI (1 vs 2 days; 1.9% vs 5.1%; and 0.1 vs 1.5%, respectively, p < 0.05). However, we found no difference in 30-day readmission and ICU admission rates. Compared to open, robotic procedures were associated with significantly shorter LOS, 30-day readmission, ICU admission, and SSI rates (2 vs 5 days; 3.8% vs 7.2%; 0.9% vs 22.1%; and 0.2% vs 1.9%, respectively, p < 0.05). For inpatient colon resection, there was no difference in CM among the three groups (p > 0.05). However, CM/LOS was significantly higher for lap compared to open procedures (2929.15 $ vs 1708.97$, p < 0.05). For outpatient cholecystectomy, inguinal and ventral hernias CM were higher in the robotic group compared to the open and lap ones, but the difference was not statistically significant. For RYGB and SG, both CM and CM/LOS were significantly higher for RAS procedures. CONCLUSION: Our study showed that RAS can result in improved clinical outcomes with similar or higher contribution margins suggesting that robotic-assisted surgery can potentially result in lower total cost of care.
引用
- El Chaar M, Alvarado L, Burfeind W, et al. Total cost of care of robotic-assisted surgery in an integrated delivery network in Eastern Pennsylvania. Surg Endosc. 2026. PMID: 42595908. doi:10.1007/s00464-026-13170-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。